ReviewCancers2019

Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go?

Jens von der Grün et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.